FENG Siqin, TANG Muyun, WU Wei, ZHANG Shuyang. Familial Hypercholesterolemia[J]. Journal of Rare Diseases, 2023, 2(1): 6-16. DOI: 10.12376/j.issn.2097-0501.2023.01.002
Citation: FENG Siqin, TANG Muyun, WU Wei, ZHANG Shuyang. Familial Hypercholesterolemia[J]. Journal of Rare Diseases, 2023, 2(1): 6-16. DOI: 10.12376/j.issn.2097-0501.2023.01.002

Familial Hypercholesterolemia

  • Familial hypercholesterolemia (FH) is a group of autosomal co-dominant genetic diseases mainly characterized by abnormal low-density lipoprotein related metabolism. It is one of the most common inherited diseases in children and one of the most serious lipid metabolism diseases which results in various life-threatening cardiovascular diseases and the complications. In recent years, the treatment protocols for FH have diversified thanks to the deeper understanding of the disease in China and abroad and the development of new lipid-lowering drugs. However, the current awareness and diagnosis rate of FH are very low. The treatment of the disease is much inadequate. This paper summarizes the clinical characteristics, diagnosis, screening strategy, and treatment of FH hoping to enhance the understanding and awareness of the disease in the society.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return